German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP). [PDF]
Homey B +12 more
europepmc +1 more source
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives. [PDF]
Renke G, Chinellato L.
europepmc +1 more source
Development and content validation of a sunlight exposure diary in patients with erythropoietic protoporphyria. [PDF]
Mathias SD +5 more
europepmc +1 more source
Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report. [PDF]
Bonchev A.
europepmc +1 more source
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art. [PDF]
Diotallevi F +8 more
europepmc +1 more source
Acute Protoporphyric Hepatopathy as the Initial Presentation of Erythropoietic Protoporphyria in Adulthood. [PDF]
Alsaleh T +3 more
europepmc +1 more source
Melanocortin 1 Receptor (MC1R): Pharmacological and Therapeutic Aspects. [PDF]
Mun Y, Kim W, Shin D.
europepmc +1 more source
Acquired erythropoietic protoporphyria secondary to myelodysplastic syndrome: from mythology to oncologyAcquired Erythropoietic Protoporphyria Secondary to Myelodysplastic Syndrome: From Mythology to Oncology. [PDF]
Urosevic-Maiwald M +3 more
europepmc +1 more source
Pathogenesis and clinical management of liver damage in porphyrias: Mechanisms and therapeutic approaches. [PDF]
Zeng T +5 more
europepmc +1 more source
Pseudoleucoderma After Injections of Afamelanotide in a Patient with Atopic Dermatitis
W Bartenwerffer +2 more
openaire +2 more sources

